Brian Adams insider trades

Open-market stock purchases and sales by Brian Adams, Chief Legal Officer at Kymera Therapeutics, Inc, from SEC Form 4 filings since Apr 15, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -32%.

Recent trades

DateStockTradeValue
Mar 2, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 2, 2026KYMR Kymera Therapeutics, IncBought (not open market)—

Companies traded

  • KYMR Kymera Therapeutics, Inc: other filings, last Mar 2, 2026
  • RLAY Relay Therapeutics, Inc: 1 buy, 40 sales, last Jul 29, 2025
  • KERX Keryx Biopharmaceuticals Inc: 26 sales, last Feb 15, 2018

Get free alerts when Brian Adams files a new trade →